AP-1 and NF-kB Regulation in Rheumatoid Arthritis and Murine Collagen-Induced Arthritis

References

• Firestein G. S. Etiology and pathogenesis of rheumatoid arthritis. Textbook of Rheumatology, 5th edition, W. N. Kelley. W.B. Saunders Company, Philadelphia 1996; 851–97
   Google Scholar
• Firestein G. S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: Passive responders or transformed aggressors?. Arthritis Rheum 1996; 39: 1781–90
   PubMed Web of Science ®Google Scholar
• Gay S., Gay R. E. Cellular basis and oncogene expression of rheumatoid joint destruction. Rheumatol. Int. 1989; 9: 105–13
   PubMed Web of Science ®Google Scholar
• Qu Z., Garcia C. H., O'Rourke L. M., Planck S. R., Kohl M., Rosenbaum J. T. Local proliferation of fibro-blast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum. 1994; 37: 212–20
   PubMed Web of Science ®Google Scholar
• Firestein G. S., Alvaro-Gracia J. M., Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immimol. 1990; 144: 3347–53
   PubMed Web of Science ®Google Scholar
• Arend W. P., Dayer J. M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990; 33: 305–15
   PubMed Web of Science ®Google Scholar
• Keyszer G. M., Heer A. H., Kriegsmann J., Geiler T., Trabandt A., Keysser M., Gay R. E., Gay S. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. Arthritis Rheum. 1995; 38: 976–84
   PubMed Web of Science ®Google Scholar
• Firestein G. S., Paine M. M., Littman B. H. Gene expression (collagenase, tissue inhibitor of metallo-proteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum. 1991; 34: 1094–105
   PubMed Web of Science ®Google Scholar
• McCachren S. S., Haynes B. F., Niedel I. E. Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry. J. Clin. Immunol. 1990; 10: 19–27
   PubMed Web of Science ®Google Scholar
• Karin M., Liu Zg, Zandi E. AP-1 function and regulation. Current Opin. Cell Biol. 1997; 9: 240–6
   PubMed Web of Science ®Google Scholar
• Pierce J. W., Lenardo M., Baltimore D. Oligo-nucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element. Proc. Nut. Acad. Sci. USA 1988; 85: 1482–6
   PubMed Web of Science ®Google Scholar
• Wirth T., Baltimore D. Nuclear factor NF-kappa B can interact functionally with its cognate binding site to provide lymphoid-specific promoter function. Embo J. 1988; 7: 3109–13
   PubMed Web of Science ®Google Scholar
• Verma I. M., Stevenson J. K., Schwarz E. M., Van Antwerp D., Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 1995; 15(9)2723–35
   Google Scholar
• Baeuerle P. A., Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988; 242: 540–6
   PubMed Web of Science ®Google Scholar
• Miyamoto S., Chiao P. J., Verma I. M. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines. Mol. Cell Biol. 1994; 14: 3276–82
   PubMedGoogle Scholar
• Beauparlant P., Hiscott J. Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis. Cyt. Growth Factor Rev. 1996; 7: 175–90
   PubMedGoogle Scholar
• Chen C. C., Manning A. M. Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-kappa B. Agents Actions. Supplements 1995; 47: 135–41
   PubMedGoogle Scholar
• Alvaro-Gracia J. M., Zvaifler N. J., Firestein G. S. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between IFN-gamma and TNF-alpha on HLADR expression, proliferation, collagenase production, and GM-CSF production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 1990; 86: 1790–8
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Morales-Ducret J., Wayner E., Elices M. J., Alvaro J. M., Zvainer N. J., Firestein G. S. α4/β1 intcgrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J. Immunol. 1992; 149: 1424–31
   PubMed Web of Science ®Google Scholar
• Schreiber E., Mattias P., Muller M., Schaffner W. Rapid detection of octamer binding proteins with mini-extracts prepared from a small number of cells. Nucl. Acids Res. 1989; 17: 6419
   PubMed Web of Science ®Google Scholar
• Manning A. M., Bell F. P., Rosenbloom C. L., Chosay J. G., Simmons C. A., Northrup J. L., Shebuski R. J., Dunn C. J., Anderson D. C. NF-KB is activated during acute inflammation in association with elevated endothelial adhesion molecule gene expression and leukocyte recruitment. J. Inflamm. 1995; 45: 283
   PubMedGoogle Scholar
• Sajjadi F. G., Takabayashi K., Foster A., Domingo R., Firestein G. S. Inhibition of TNF-alpha gene expression by adenosine: The role of A3 adenosine receptors. J. Immunol. 1996; 156: 3435–42
   PubMed Web of Science ®Google Scholar
• Westwick J. K., Weitzel C., Minden A., Karin M., Brenner D. A. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-.Iun kinase. J. Biol. Chem. 1994; 269: 26396–401
   PubMed Web of Science ®Google Scholar
• Woessner J. F., Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991; 5: 2145–54
   PubMed Web of Science ®Google Scholar
• Dayer J. M., Beutler B., Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 1985; 162: 2163–8
   PubMed Web of Science ®Google Scholar
• Barnes P. J., Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. New Eng. J. Med. 1997; 336: 1066–71
   PubMed Web of Science ®Google Scholar
• Stein B., Baldwin A. S., Jr., Ballard D. W., Greene W. C., Angel P., Herrlich P. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. Embo J. 1993; 12: 3879–91
   PubMed Web of Science ®Google Scholar
• Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herrlich P., Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 1987; 49: 729–39
   PubMed Web of Science ®Google Scholar
• Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705–16
   PubMed Web of Science ®Google Scholar
• Cross S. L., Halden N. F., Lenardo M. J., Leonard W. J. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes. Science 1989; 244: 466–9
   PubMed Web of Science ®Google Scholar
• Baeuerle P. A., Henkel T. Function and activation of NF-kappa B in the immune system. Ann. Rev. Immunol. 1994; 12: 141–79
   PubMed Web of Science ®Google Scholar
• Zhong H., Su Yang H., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-kappa B is regulated by the I kappa B-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 1997; 89: 413–24
   PubMed Web of Science ®Google Scholar
• Bennett B. L., Lacson R. G., Chen C. C., Cruz R., Wheeler J. S., Kletzien R. F., Tomasselli A. G., Heinrikson R. L., Manning A. M. Identification of signal-induced I kappa B-alpha kinases in human endothelial cells. J. Biol. Chem. 1996; 271: 19680–8
   PubMed Web of Science ®Google Scholar
• Auphan N., Di Donato J. A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286–90
   PubMed Web of Science ®Google Scholar
• Deleuran B. W., Chu C. Q., Field M., Brennan F. M., Mitchell T., Feldmann M., Maini R. N. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum. 1992; 35: 1170–8
   PubMed Web of Science ®Google Scholar
• Su B., Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Current Opin. Immunol. 1996; 8: 402–11
   PubMed Web of Science ®Google Scholar
• Pierce R. A., Sandefur S., Doyle G. A.R., Welgus H. G. Monocytic cell type-specific transcriptional induction of collagenase. J. Clin. Invest. 1996; 97: 1890–9
   PubMed Web of Science ®Google Scholar
• Handel M. L., McMorrow L. B., Gravallese E. M. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum. 1995; 38: 1762–70
   PubMed Web of Science ®Google Scholar
• Marok R., Winyard P. G., Coumbe A., Kus M. L., Gaffney K., Blades S., Mapp P. I., Morris C. J., Blake D. R., Kaltschmidt C., Baeuerle P. A. Activation of the transcription factor nuclear factor-kappa B in human inflamed synovial tissue. Arthritis Rheum. 1996; 39: 583–91
   PubMed Web of Science ®Google Scholar
• Asahara H., Fujisawa K., Kobata T., Hasunuma T., Maeda T., Asanuma M., Ogawa N., Inoue H., Sumida T., Nishioka K. Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum. 1997; 40: 912–8
   PubMed Web of Science ®Google Scholar
• Fujisawa K., Aono H., Hasunuma T., Yamamoto K., Mita S., Nishioka K. Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis Rheum. 1996; 39: 197–203
   PubMed Web of Science ®Google Scholar
• Asahara H., Asanuma M., Ogawa N., Nishibayashi S., Inoue H. High DN A-binding activity of transcription factor NF-kappa B in synovial membranes of patients with rheumatoid arthritis. Biochem. Mol. Biol. Internal. 1995; 37: 827–32
   PubMedGoogle Scholar
• Tsao P. W., Suzuki T., Totsuka R., Murata T., Takagi T., Ohmachi Y., Fujimura H., Takata I. The effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis. Clin. Immunol. Immunopathol. 1997; 83: 173–8
   PubMedGoogle Scholar
• Rutter J., Benbow U., Coon C. I., Brinckerhoff C. E. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta in human fibroblasts and BC-8701 breast cancer cells. J. Cell. Biochem. 1997; 66: 322–36
   PubMed Web of Science ®Google Scholar
• Tardif G., Pelletier J. P., Dupuis M., Hambor J. E., Martel-Pelletier J. Cloning, sequencing and characterization of the 5'-flanking region of the human collagenase-3 gene. Biochem. J. 1997; 323: 13–6
   PubMed Web of Science ®Google Scholar
• Pendas A. M., Balbin M., Llano E., Jimenez M. G., Lopez-Otin C. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13). Genomics 1997; 40: 222–33
   PubMed Web of Science ®Google Scholar